爱尔眼科(300015) - 2015 Q3 - 季度业绩预告

Financial Performance - The company's net profit attributable to shareholders is expected to be approximately between 344.15 million and 369.64 million CNY, representing a growth of 35% to 45% compared to the same period last year, which was 254.93 million CNY[3] - The estimated impact of non-recurring gains and losses on net profit for the reporting period is around -7 million CNY[6] Market Factors - The increase in performance is attributed to the continuous release of demand in the ophthalmology market, expansion of operational scale, and enhanced brand influence[5]